Clever, Personable, and Unconventional: Plus Therapeutics Presents Data at ESMO Congress 2022
Celebrating Innovative Cancer Treatments with Plus Therapeutics Introduction AUSTIN, Texas, Aug. 23, 2022 (GLOBE NEWSWIRE) – Plus Therapeutics, Inc. (Nasdaq: PSTV) is making waves in the medical world with its cutting-edge approach to cancer treatment. The company focuses on developing targeted radiotherapeutics for rare and difficult-to-treat cancers, offering hope to patients who may have few…